Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Jul
11
2016
Senate to Vote on Comprehensive Addiction and Recovery Act Conference Report; CMS Issues Proposed Rule to Medicare Physician Fee Schedule, OPPS and ASC System Changes Squire Patton Boggs (US) LLP
Nov
8
2023
Ohio Legalizes Recreational Marijuana, But Employers’ Ability to Enforce Workplace Drug Policies Remains Intact (US) Squire Patton Boggs (US) LLP
Sep
19
2016
Continuing Resolution and Zika Negotiations Persist, Vote Could Occur Early This Week Squire Patton Boggs (US) LLP
Jan
2
2024
New U.S. Action Against Wine Bottle Imports Squire Patton Boggs (US) LLP
Nov
12
2020
Brexit: Phased Approach for Northern Ireland Protocol (NIP) for the Pharmaceuticals Sector Squire Patton Boggs (US) LLP
Dec
3
2020
EU’s New Pharmaceutical Strategy Squire Patton Boggs (US) LLP
May
9
2017
Does Southern Hemisphere Rugby Have A Recreational Drug Problem? Squire Patton Boggs (US) LLP
Jan
1
2021
Federal Circuit Endorses the Doctrine of Equivalents Again for Lilly’s ALIMTA®: Different Amendment, Same Result Squire Patton Boggs (US) LLP
May
22
2017
FDA User Fee Reauthorization Moves to Full Committee; HHS Further Delays Bundled Payment Models and Changes to 340B Drug Discount Program Squire Patton Boggs (US) LLP
Dec
20
2017
FDA Issues Guidance on Clinical and Patient Decision Support Software Squire Patton Boggs (US) LLP
Nov
29
2021
Judge Blocks Portions of Centers for Medicare and Medicaid Services (CMS) Vaccine Mandate (US) Squire Patton Boggs (US) LLP
Jan
31
2023
Bankruptcy Court Doors Swing Open For Cannabis Companies, But Just Slightly Squire Patton Boggs (US) LLP
Mar
19
2020
Can Coverage for COVID-19 Be Excluded? Squire Patton Boggs (US) LLP
Oct
4
2023
Key Areas of Focus in U.S.-China Relations and Their Impact on Businesses in the 118th Congress Squire Patton Boggs (US) LLP
Nov
22
2023
FDA Delays Enforcement of MOCRA Deadlines for Facility Registration and Product Listing to July 1, 2024 Squire Patton Boggs (US) LLP
Nov
11
2016
Recreational Marijuana Use Legalized in Four States, But Employers’ Ability to Enforce Workplace Drug Policies Undisturbed Squire Patton Boggs (US) LLP
Jul
14
2020
The Bio/Pharma Beat July 2020 Squire Patton Boggs (US) LLP
Jul
24
2020
Sixth Circuit Panel Dismisses Motion to Enforce Writ of Mandamus Squire Patton Boggs (US) LLP
Nov
6
2020
Election 2020 Puts Cannabis Center Stage Squire Patton Boggs (US) LLP
May
7
2024
Navigating the Regulatory Maze: Hemp Industry Calls for Additional Federal Action Squire Patton Boggs (US) LLP
Jan
2
2021
Twelve Cannabis Plant Patents and Counting Squire Patton Boggs (US) LLP
Jan
24
2018
Here’s a Nug of Information: California Is Now Accepting Cannabis-Related Trademarks Squire Patton Boggs (US) LLP
Feb
22
2018
Is the Restaurant Trade “Dining Out”? Squire Patton Boggs (US) LLP
Mar
12
2018
An analysis of the DCMS Select Committee Report: ‘Combatting doping in sport’ – Part 3 – ‘UK Athletics’ and ‘Criminalisation of doping in sports’ Squire Patton Boggs (US) LLP
Jan
18
2022
US Federal Labor Viewpoints – Week of January 10, 2022 Squire Patton Boggs (US) LLP
Jun
14
2019
That Didn’t Take Long: Ninth Circuit’s Decision in Garvin v. Cook Invs. NW is Challenged Squire Patton Boggs (US) LLP
Mar
16
2015
House And Senate Committees To Mark Up Budget Resolutions; How Will Congress Deal With The Sequester; Debt Limit Reached Squire Patton Boggs (US) LLP
Jan
4
2023
IDR Payment Disputes are Far Outpacing Projections, Creating Backlogs Squire Patton Boggs (US) LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins